Paper33688372
Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
Fan C and 2 others. Comput Math Methods Med, 2021. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival. Papers, record 33688372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33688372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Transcription Factors | Major topic |
| Biomarkers, Tumor | |
| Computational Biology | |
| Disease-Free Survival | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Kaplan-Meier Estimate | |
| Lymphocytes, Tumor-Infiltrating | |
| Middle Aged | |
| Prognosis | |
| Proportional Hazards Models | |
| Risk Factors | |
| Tumor Microenvironment |
Source PubMed
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32391054 | Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management. | Front Genet | 2020 | https://conductscience.org/library/papers/32391054 | PubMed |
| 2 | 21743061 | A Lasso regression model for the construction of microRNA-target regulatory networks. | Bioinformatics | 2011 | https://conductscience.org/library/papers/21743061 | PubMed |
| 3 | 31747912 | A novel epigenetic signature for overall survival prediction in patients with breast cancer. | J Transl Med | 2019 | https://conductscience.org/library/papers/31747912 | PubMed |
| 4 | 19502425 | Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19502425 | PubMed |
| 5 | 26549855 | A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. | Sci Rep | 2015 | https://conductscience.org/library/papers/26549855 | PubMed |
| 6 | 25605792 | limma powers differential expression analyses for RNA-sequencing and microarray studies. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/25605792 | PubMed |
| 7 | 22945654 | Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers. | Oncogene | 2013 | https://conductscience.org/library/papers/22945654 | PubMed |
| 8 | 21779462 | MYC and Breast Cancer. | Genes Cancer | 2010 | https://conductscience.org/library/papers/21779462 | PubMed |
| 9 | 22945800 | EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. | Cell Mol Life Sci | 2012 | https://conductscience.org/library/papers/22945800 | PubMed |
| 10 | 15171706 | Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. | J Mol Endocrinol | 2004 | https://conductscience.org/library/papers/15171706 | PubMed |
| 11 | 11972862 | Predictive and prognostic markers for invasive breast cancer. | Pathol Int | 2002 | https://conductscience.org/library/papers/11972862 | PubMed |
| 12 | 12013528 | Prognostic factors in breast cancer: current and new predictors of metastasis. | J Mammary Gland Biol Neoplasia | 2001 | https://conductscience.org/library/papers/12013528 | PubMed |
| 13 | 21345283 | Gene signatures of breast cancer progression and metastasis. | Breast Cancer Res | 2011 | https://conductscience.org/library/papers/21345283 | PubMed |
| 14 | 31762828 | Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer. | J Cancer | 2019 | https://conductscience.org/library/papers/31762828 | PubMed |
| 15 | 19029958 | Reflecting on 25 years with MYC. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/19029958 | PubMed |
| 16 | 21501481 | Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. | BMC Cancer | 2011 | https://conductscience.org/library/papers/21501481 | PubMed |
| 17 | 25462566 | FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/25462566 | PubMed |
| 18 | 23022474 | Cancer genetics and genomics of human FOX family genes. | Cancer Lett | 2013 | https://conductscience.org/library/papers/23022474 | PubMed |
| 19 | 21546393 | Molecular signatures database (MSigDB) 3.0. | Bioinformatics | 2011 | https://conductscience.org/library/papers/21546393 | PubMed |
| 20 | 27487029 | RNAseq Analyses Identify Tumor Necrosis Factor-Mediated Inflammation as a Major Abnormality in ALS Spinal Cord. | PLoS One | 2016 | https://conductscience.org/library/papers/27487029 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38178084 | Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinoma. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38178084 | PubMed |
| 36673982 | Identification of a Novel Gene Signature with DDR and EMT Difunctionalities for Predicting Prognosis, Immune Activity, and Drug Response in Breast Cancer. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/36673982 | PubMed |
| 36292695 | Basement-Membrane-Related Gene Signature Predicts Prognosis in WHO Grade II/III Gliomas. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/36292695 | PubMed |
| 35694087 | Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis. | Gland Surg | 2022 | https://conductscience.org/library/papers/35694087 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33688372
GET https://conductscience.org/api/papers/v1/33688372/references?page=2